Visium Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

Visium Asset Management’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-400,000	Closed	-$11.4M	–	692
2015 Q4	$11.4M	Hold	400,000	–	–	0.17%	142
2015 Q3	$6.99M	Hold	400,000	–	–	0.1%	221
2015 Q2	$7.21M	Sell	400,000 -25,000	-6%	-$342K	0.1%	217
2015 Q1	$5.29M	Buy	425,000 +25,000	+6%	+$311K	0.08%	252
2014 Q4	$4.7M	Buy	400,000 +67,484	+20%	+$786K	0.07%	268
2014 Q3	$4.37M	Buy	+332,516	New	+$4.31M	0.06%	302

Other funds holding LOXO

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Visium Asset Management's LOXO Position: Q1 2016 in Review

Visium Asset Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2016, closing a stake of 400,000 shares — an estimated $11.4M sold.

Visium Asset Management first reported a position in LOXO in Q3 2014 and held it in 6 quarters. The position peaked at $11.4M in Q4 2015. 67 funds tracked by Wall St. Rank hold LOXO as of Q1 2016.

Visium Asset Management reported no remaining Loxo Oncology, Inc position as of Q1 2016 after selling out during the quarter.
Visium Asset Management sold 400,000 Loxo Oncology, Inc shares in Q1 2016, an estimated $11.4M.
Visium Asset Management first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 6 quarters.
Visium Asset Management's Loxo Oncology, Inc position peaked at $11.4M in Q4 2015.
67 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2016.

Based on Visium Asset Management's 13F filing for Q1 2016, filed 16 May 2016.